Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Testosterone · Testim, Testoderm Tts

Small molecule · Agonist of androgen receptor (AR) · developed by Alza

Approved FDA, Dec 1997
1 Registered trials

What is Testosterone?

Testosterone is an endogenous androgen that is used as a topical gel for testosterone replacement therapy in adult males. It acts on androgen receptors to maintain male sex characteristics.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Testim, Testoderm Tts, Vogelxo
Drug type
Small molecule
Targets
androgen receptor (AR)
Mechanism
Agonist of androgen receptor (AR)
Therapy area
Endocrine
Developer
Alza
In trials of
AMRX
FDA status
Approved as Testim, Testoderm Tts, Vogelxo (December 18, 1997), NDA020791 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of Jul 15, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02110368 Phase 3 Primary Hypogonadism Completed AMRX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Hypogonadotropic HypogonadismPrimary Hypogonadism

Other drugs acting on AR

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.